1124 Alnylam PH1 approval
BioCentury & Getty Images


With Oxlumo’s approval, Alnylam aims to speed access with new value-based pricing framework

Nov 25, 2020 | 12:25 AM GMT

With the approval of Oxlumo to treat primary hyperoxaluria, Alnylam is aiming to accelerate patient access to the ultra-rare disease therapy by building

Read the full 496 word article

How to gain access

Continue reading with a
two-week free trial.